The treatment protocols for depression, ADHD, etc. developed by NeuroResearch Clinics, Inc. involves the use of 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine and L-dopa aka dopa with urinary serotonin and dopamine neurotransmitter testing. 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa freely cross into the brain then are synthesized into serotonin and dopamine neurotransmitter molecules by the brain. Giving 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa is the only way to increase brain levels of serotonin and dopamine to levels needed for symptoms of disease such as depression, ADHD, etc. to be under control.

  With the depression, ADHD, etc. protocol for adults start at level 1 dosing of 5-HTP aka 5-HTP or 5 HTP and tyrosine aka L-tyrosine then in one week if relief of symptoms are not obtained the dosing is increased to level 2 dosing of 5-HTP aka 5-HTP or 5 HTP and tyrosine aka L-tyrosine. If no relief of symptoms is seen in one week on level 2 dosing the 5-HTP aka 5-HTP or 5 HTP and tyrosine aka L-tyrosine is increased to level 3 dosing. At this point approximately 80% of patients with depression will find relief of symptoms.

  If there is no relief of symptoms on level 3 5-HTP aka 5-HTP or 5 HTP and tyrosine aka L-tyrosine dosing urinary serotonin and dopamine neurotransmitter testing is ordered and the consultant recommendations are followed until the patient achieves complete relief of symptoms or both the serotonin and dopamine are in the serotonin and dopamine phase 3 therapeutic range. 

  Once serotonin and dopamine are in the phase 3 therapeutic range if no relief of symptoms of depression is seen 100% of patients not responding to 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa are actually suffering from depressive bipolar disorder. These are depression patients who have not been previously diagnosed with bipolar depression. The recommendation at that point is to continue the 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa and start a bipolar drug such as lithium 300 mg twice day, Depakote 500 mg twice a day or Lamictil 50 mg a day. After one week on the bipolar drug you now have 100% relief in  patients with depression. On the link to the right titled, "depression chapter" is a depression chapter written for the new medical text book editor Ingrid Kohlstadt, MD of Johns Hopkins outlining in detail this approach in treating depression with 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, L-dopa aka dopa, and urinary serotonin and dopamine neurotransmitter testing.

 NeuroResearch Clinics, Inc. has been studying ADHD for several years. In 2006 we started a formal pilot study with an independent clinic in Dallas Texas to verify ADHD results. The findings of the ADHD pilot study were that 100% of children with ADHD who took their pills properly achieved relief of symptoms in treatment of ADHD. Based on this study we entered into agreement with the University of North Texas at Denton to perform a double blind placebo controlled study of ADHD. This ADHD study by the University of North Texas is detailed on a separate web page on this web site. To access the ADHD web page go to the top left of this web page and click on the ADHD study link.

  If you have a child with ADHD you do not have to wait for the University of North Texas ADHD to finish. The ADHD treatment developed by NeuroResearch is available now. Contact NeuroResearch Clinics on the blue colored link at the top middle of this page and we can help you find an ADHD caregiver using the approach developed by NeuroResearch Clinics, Inc. to treat ADHD.

  Real treatment for dementia is something that has eluded medicine. Using 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa in patients with dementia or patients who have been diagnosed with dementia or Alzheimer's Disease is showing profound promise. Dementia appears to be a multi-factorial / multi-etiology disease where serotonin and dopamine may or may not be the driving cause. In cases where serotonin and dopamine is the driving cause results are profound. The case studies to the right submitted by care givers documents results of treatment. Of interest with dementia patients is the fact that these patients need to have someone around to insure they are taking their pills properly. If they miss taking their 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa very quickly they relapse and all the confusion of dementia returns.

  Results in treatment of obesity with 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa with urinary serotonin and dopamine neurotransmitter testing show that average weight loss the first month is 16.9 pounds. At the heart of the NeuroResearch Clinics treatment approach is our computer program written in 1995. This computer program is provided to clinics free of charge. The computer programs answers the question, "Is the patient on track to make goal weight or to adjustments have to be made?" The sooner it is realized that the patient is not on track to make goal weight and adjustments are made optimization of results is facilitated. This computer program is hooked up to a huge data base. Data in the data base goes back to 1995 and represents almost 1.5 million patient-years of medical weight loss data from over 600 clinics. This data has been an invaluable tool used in NeuroResearch Clinic's research of obesity. It is the largest weight loss data base in the world, bar none.

  Installation of a weight management program into a clinic is a lot of work and not all clinics who use the NeuroResearch approach have weight programs. If you are interested in finding a clinic with a NeuroResearch weight loss program please contact us.

  In working with 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa then looking at Parkinson's disease, where the standard approach in medicine is to use L-dopa aka dopa from the start of treatment, it was realized that virtually all the problems encountered in the treatment of Parkinson disease patients were caused by improper use of 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa. If you do not give proper levels of 5-HTP aka 5-HTP or 5 HTP the serotonin precursor with L-dopa aka dopa serotonin is depleted at which point the L-dopa aka dopa may quit working and a host of serotonin deficiency diseases develop such as depression, ADHD, etc. If you do not give adequate levels of cysteine L-dopa aka dopa depletes the sulfur amino acids. Carbidopa commonly used with L-dopa aka dopa depletes both serotonin and dopamine peripherally outside of the brain. To the right are links to in-depth writings about Parkinson Disease management and how to use L-dopa aka dopa properly without getting into the problems that plague treatment of Parkinson patients currently in medicine.

  A number of serotonin and dopamine related neurotransmitter diseases such as depression, ADHD, etc. are listed on the link at the top of this page. Over 90% of patients suffering with one of these diseases such as depression, ADHD, etc. have 3 or more diseases present at the same time. The starting point for treatment of each of these diseases such as depression, ADHD, etc. under NeuroResearch protocols is always the same since the cause is the same, serotonin and dopamine levels that are not high enough to prevent disease such as depression, ADHD, etc. symptoms. To the left are two cases studies in patients with multiple diseases such as depression, ADHD, etc. In the top case study fibromyalgia is one of the diseases. While fibromyalgia is not specifically discussed on this web page it is noted that we have seen 100% relief of fibromylagia symptoms under the NeuroResearch protocols.

  Anti-aging would seem to go hand in hand with the dementia discussion above. Intriguing here, as discussed on the link to the right is the fact the urinary serotonin and dopamine neurotransmitter testing has been shown to be a predictor of cognitive decline, functional decline, and mortality. The serotonin and dopamine testing result problems seen leading to these conclusions are easily corrected with the approach of NeuroResearch Clinics. What we don't know is if correcting the urinary serotonin and dopamine neurotransmitter problems seen on the labs and proven as a predictor will lead to preservation of cognitive function, general function, and decreased mortality. But from everything known it would appear that this is possible.

  On the left are more case studies submitted by care givers attesting to the effectiveness of the serotonin and dopamine approach of NeuroResearch Clinics. A problem seen is that care givers and patients seem to want to put each disease such as depression, ADHD, etc. in a neat and separate box to be treated individually when the real cause is the same, serotonin and dopamine neurotransmitter levels that are not high enough to prevent disease such as depression, ADHD, etc.

  Serotonin and dopamine neurotransmitter levels have a role directly or indirectly in virtually every function in the body. There is constant surprise at NeuroResearch Clinics with reports from clinics regarding treatment of disease such as depression, ADHD, etc. that might not be expected to respond to other approaches. The bottom line recommendation to clinics is, "If it appears that the disease such as depression, ADHD, etc. might have a serotonin or dopamine component a trial of 5-HTP aka 5-HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa aka dopa is indicated.

  Some diseases such as dementia may have multiple causes (multi-etiology) and have multiple contributing factors. While other disease such as depression and fibromyalgia are 100% caused by dysfunction of serotonin and dopamine control. In the multi-factorial / multi-etiology diseases if the dominating component is serotonin and dopamine amazing results will be seen. An empirical trial for 6 to 8 weeks following the NeuroResearch protocol will sort out the multi-etiology / multi-factorial patients that have serotonin and dopamine as the driving force behind their disease.